Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

pda 1 > pharmacokinetics > Flashcards

pharmacokinetics Flashcards

1
Q

Pharmacokinetics:

A

the effect of the body on the drug

Transfer of a drug almost always crosses a membrane

Absorption, distribution and excretion of drugs all involve cell membranes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Compounds can diffuse readily thru membranes via passive diffusion

A

the rate of passive diffusion is determined by the partition coefficient of the drug into oil from water and its concentration gradient across the membrane

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Most drugs are in this type of form

A

weak acids or bases

ligands bind to receptors using the ionic charges

Weak acids exist in an equilibrium:
HA A- + H+
(HA dominates when pH is acidic and theres lots of H)
HA is not charged and will passively diffuse thru cell membranes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

how is the ratio of [HA]/[A-]

A

the pH of the environment , the pKa of the drug

The HH equation:
Log [protonated]/[unprotonated] = pKa- pH

it is the unprotonated that can diffuse and is lipid soluble

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what about bases

A

B + H+ BH +

you can use the HH equation
log [protonated]/[unprotonated] = pka - pH
the unprotonated form is B and uncharged and therefore more likely to pass thru membranes

the protonated form is BH +

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

ion trapping

A

acidic drugs accumulate on the side of the membrane thats more basic

basic drugs accumulate on the side thats more acidic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

movement via passive diffusion is

A

bidirectional and driven by the concentration gradient

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

carrier mediated transport

A

transport of a molecule across a barrier is mediated by binding of solute to a protein transporter

Serves multiple purposes: can move hydrophilic molecules thru bilayer, can move molecules against their concentration gradient, provides specificity (eg sugars)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

facilitated diffusion

A

carrier mediated, concentration-gradient driven, no requirement for the input of energy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

activate transport

A

carrier mediated, moves solute against its concentration gradient, therefore requires energy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

p-glycoprotein

A

an ABC carrier or pump, ABC (ATP-binding cassette), family of proteins

Primarily binds to lipophilic drugs that have entered cells via passive diffusion and mediates their efflux from the cell

Energy is provided by ATP hydrolysis

Is encoded by the multidrug resistance gene (a gene for which there is genetic polymorphism among humans and is inducible)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Secondary active transport

A

carrier mediated; move 2 different solutes in the same (symport) or opposite (antiport) directions

most often couple solute movement against its concentration gradient to the movement of sodium or hydrogen down their concentration gradients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Bioavailability (F)

A

Fraction of the of the administered dose that enters the circulation

IV=1
orally administered drugs are almost never completely bioavailable (incomplete absorption, first pass effect)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Bioequivalence

A

Same drug, same route of administration, drug enters the circulation at the same rate

used to compare formulations (generic)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

orally administered drugs

A

absorbed into the circulation from the GI tract, mostly via passive diffusion (passive absorption)- favors absorption of unionized drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Characteristics of the absorptive regions of the GI tract

A

Stomach- very acidic (pH 1-2) lined with thick mucus, small surface area, limited absorption (even of weak acids)

Upper intestine- pH is about 7 very large absorptive surface area (200 m2)

The vast majority of drug absorption from the GI tract occurs in the upper intestine, even if the drug is ionized at the pH of this environment becuase equilibrium is not reached with moving blood

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

gastric emptying impact on drug absorption

A

increased gastric emptying will increase the rate of drug absorption

18
Q

dissolution of solid drug prep on drug prep

A

will affect the rate of absorption, its affected by how the drug is formulated (coatings, particle sizes for example)

controlled release prep, usually accomplished by coating the active drug with hard to dissolve agents, results in slow, uniform drug dissolution and absorption

pros: slower absorption results in decreased freq of dosing, more uniform conc of drug in the blood
cons: greater variability among pts and toxicity if all the drug is released at once

enteric coatings: protect the drug from the stomach acid and the stomach from the drug, better taste, but the coating ant be completely impervious bc itll retard/variable absorption in the intestine

19
Q

other ways of giving drugs

A

sublingia, buccal

blood drains into the superior vena cava (avoids the liver for the 1st pass)

small surface area, so drug needs to be lipophillic (readily pass through membranes)

rectal admin: 50% less 1st pass, can be variable absoprtion, can be incomplete irritating to rectal mucosa, uncomfortable

20
Q

Transdermal administration

A

thru skin, epidermis is nearly complete barrier to non-lipophillic substance, but its permeable to lipophillic drugs, best if skin is hydrated

21
Q

Parenteral injection

A 
without intestine
IV
SubQ (drug cant be irritating, painful, damaging, can add vasoconstrictors to delay absorption) and IM- drug diffuses to nearby capillary where it enters the blood stream

drugs distribute to lungs before the liver
lung is metabolically active, with a large capillary bed, has metabolic enzymes, filters particles and volitile agents can diffuse into expired air, lipophilic agents can accumulate, redistribute

22
Q

IV injection/infusion

A

completely bioavailable (F=1) achieve immediate action, drug delivery can be highly controlled dose and rate of delivery can be rapidly adjusted

anesthetic, ER treatments, irritating agents are diluted byt he entire blood volume

pros: control, adjust based upon pt response, control over the rate of admin, bolus or slow diffusion
cons: route of no return, needs close monitring, patent vein, experienced med staff

23
Q

lipophilic vs large hydrophobic vs protein admin

A

lipophilic drugs: rate of absorption depends on drug solubility in IF area of capillary ben in the vicinity

Large hydrophilic drugs (insulin): pass thru large aqueous channels in the capillaries

Proteins: enter the circulation slowly via the lymphatic system (eg Ag in immunization)

24
Q

administration to the airway for pulmonary absorption

A

used to deliver volatile agents, rapid access to the circulation (general anesthetics) drugs to treat the airway

25
Q

topical application of drugs

A

Mucous membranes: best for lipophilic drugs
Eye: requires absorption thru the cornea, can get systemic effects if drugs gets into the general circulation via the nasolacrimal canal, can delay absorption and reduce systemic effects with formulations, inserts

26
Q

Extent of and rate of drug delivery depend on

A
  1. Blood flow (1st phase, highly perfused organs recieve most drug, equilibration is rapid; second phase, more poorly perfused organs, equilibration is very slow)
  2. Capillary permeability: endothelial junctions are loose, allows for paracellular movement, with hydrostatic pressure pushing out the drug (not in brain BBB), lipids diffuse more easily, for weak acids/bases pH will influence distribution (but usually not much bc ph is the same as blood in most compartments)
  3. Drug binding to plasma proteins (albumin for acidic drugs, alpha1 acid glycoproteins for basic drugs)**
    binding is low affinity and easily reversible and binding follows laws of mass action ( [DP] = [Protein tot][ drug]/ (Kd + [drug]) ) for most drugs given repeatedly, [drug] is relatively constant so [DP] is also constant
27
Q

protein binding

A
  1. protein binding prevents from leaving the circulation
  2. Drug responses, toxicity, metabolism are all a function of the drug that is free (not protein bound)
  3. at equilibrium amount of free drug is constant, so protein binding is not that important to effect
  4. Equilibrium is perturbed transiently if (plasma protein concentrations suddenly change, there are changes in exogenous or endogenous competitors for the binding sites, but these changes usually transient and important for drugs that have a narrow therapeutic window

Extent of protein binding can be affected by disease states that alter plasma binding proteins long term (liver disease ie reduced albumin and reduced protein binding, it could be necessary to decrease the dose of drug) (immune activation- Chrons or arthritis, can increase alpha1- acid glycoprotein it could be necessary to increase the dose of drug

28
Q

Tissues accumulate drugs

A

tissues can accumulate drugs and serve as slowly releasing resevoirs, Lipophilic drugs can be stored for long periods in the fat THC reintoxication syndrome, drugs that bind to heavy metals

29
Q

Redistribution

A

a mechanism for the termination of action of a drug, due to its redistribution from the tissue or site of action to tissues in which it is inactive

Can be a factor for: highly lipid soluble drugs, drugs acting on high blood flow organ, drugs administered by IV injection or inhalation

Drug distribution in brain: able to get in via unionized, not protein bound and highly lipophilic, substrates AA or sugar carriers (brain can be opposed via P-glycoprotein, lipophilic drugs inducible, and organic anion transporting polypeptide OATP

Fetal plasma is acidic so holds on to basic drugs

30
Q

Renal excretion of a drug

A

glomerular filtration: unbound drug enters the tubular lumen, if its the only process involved in the renal excretion of a drug, its rate of elimination will be the same as the glomerular filtration rate.

active tubular secretion: proximal tubule, drug is moved into tubular lumen, regardless of conc. gradient via energy pumps- P-glycoproteins (multi drug resistance results in excretion rate thats greater than the GFR)

Passive tubular REAB- proximal and distal tubules, passive diffusion of unionized drugs, follows the concentration gradient (lumen-> blood as the urine becomes conc as water is REAB), for acid its REAB as HA, excreted as A- form, alkalinization of the urine promotes excretion

31
Q

biliary and fecal excretion

A

canalicular membrane of hepatocytes expresses ABC transporters, these function to move drugs into bile. Together with REAB of drug into plasma from intestine contributes to interohepatic recycling

32
Q

lag time, rate of absorption, extent of absorption, theraputic window

A

lag time: time to peak plasma concentration
Rate of absorption:
Extent of absorption: is concerned with the area under the curve

Therapeutic window: minimum toxic concentration to minimum effective concentration

The effectiveness of the drug is measured by the concentration of the drug in the circulation, but drugs that are in other compartments are measured by the volume of distribution

33
Q

how to calculate the volume of the solvent that a drug is placed in

A

total amount of a solute is known, its concentration is known
Then you remove an aliquot and get the concentration

amount of drug/concentration of aliquout = volume of container= volume of distribution

amount of drug in the body/ plasma concentration using the total plasma concentration (bound and unbound) can also use blood or serum concentration

34
Q

volume of distribution

A

immediately after administration (time zero, Co), the entire drug dose is in the body, but not all in circulation (even if IV) at a later time the drug has been eliminated so we dont know the amount. but you can calculate at Co by extrapolation of the elimination phase (linear portion where hypothetically 0 elimination has occured)

Vd= D/Co (D=dose), assumption that concentration of drug is the same throughout the body is the same as the plasma

if drug stays completely in plasma: Vd is small 2.8 liters for 70kg body
if drug moves with water: Vd=total body volume (70 l = 70 kg)
if Vd is larger than body then drug is sequestered in a non plasma compartment

D= Vd * Co if you want to calculate a dose for initial plasma concentration (with a known Vd)

to factor in bioavailability : D= Vd * Co/ F

F determines the area under the curve, and the does not alter the the kinetics of elimination

35
Q

Clearance of the drug from the body

A

clearance = rate of elimination / concentration

unit of clearance: volume/time

Clearance is additive if a drug is eliminated by multiple routes, if the processes involved in the clearance of a drug are not saturated, then clearances is constant (this is the typical behavior at therapeutic concentration

most drugs are cleared in a 1st order decay process
Slope of clearance= -k el/2.3

T1/2 = .69/ kel constant for a 1st order process, as most drugs are eliminated by this process

36
Q

Phases for drugs given IV

A

alpha phase: distribution

beta phase: elimination, slope = -Kel/2.3

37
Q

clearance for saturated elimination processes

A

clearance is not a constant because rate of elimination cannot increase with increasing concentration

Rate of elimination = Vmax * C / (Km +C )

When C is very large compared to Km , rate of elimination is equal to Vmax and independent of concentration

38
Q

zero order kinetics

A

aka capacity limited, dose dependent, MM elimination

As concentration increases, clearance decreases, Kel decreases, t1/2 increases

Half life and clearance are not constants (ethanol, aspirin, phenytoin)

39
Q

1st order kinetics

A

clearance is defined by elimination rate constant and Vd

Cl= Kel * Vd

And T 1/2 = .69/kel

t1/2 = .69* Vd/CL

40
Q

repeated dosing of drugs cleared by 1st order kinetics

A

Drugs will accumulate until the amount added into the body and the amount eliminated are equal. At that point the concentration of the drug in the plasma reaches a steady state

Dose/dosing interval = Cl *Css /F

to reach Css takes 4-5 half lives when same dose is given

maintanence dose = Css * CL * DI / F

pda 1 (11 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions